Nuvation Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Nuvation Bio Inc. (NUVB) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.040.040.100.770.22
Short-Term Investments0.470.570.560.630.19
Cash & Short-Term Investments0.500.610.660.770.22
Accounts Receivable0.020.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.010.000.000.000.00
Total Current Assets0.530.620.670.770.22
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Intangible Assets0.000.000.000.000.00
Other Non-Current Assets0.010.000.000.000.14
Total Non-Current Assets0.010.010.000.000.01
Total Assets0.540.620.670.780.22
Current Liabilities
Accounts Payable0.010.000.000.020.01
Short-Term Debt0.010.000.000.000.00
Accrued Liabilities0.030.010.010.010.00
Deferred Revenue0.010.000.000.000.00
Other Current Liabilities0.030.000.000.000.00
Total Current Liabilities0.060.010.010.020.01
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities0.020.000.000.010.00
Total Liabilities0.080.020.020.030.01
Stockholders' Equity
Common Stock1.370.950.930.910.29
Retained Earnings-0.91-0.34-0.27-0.16-0.07
Accumulated Other Comprehensive Income0.000.00-0.010.000.00
Additional Paid-in Capital0.000.000.000.000.01
Minority Interest0.000.000.000.000.14
Shares Outstanding0.340.220.220.220.00
Total Stockholders' Equity0.460.610.660.750.22
Total Liabilities & Equity0.540.620.670.780.22